Wish you could get rid of your COVID-19 symptoms sooner? Be part of a new study

A recently published Providence Research Network study found that patient-provider communication, unmet social needs, and other factors can influence whether patients adhere to their ASCVD treatments.

An interview with Providence researchers for the news website Healthcare Intelligence looks at findings from a recent study on the impact of an AI solution on provider documentation burden and burnout

When metastatic breast cancer rocked Renee Leaf's world, she found strength in her life's treasures and a Providence Swedish care team determined to save her life. Watch the video and learn more.

For decades, brain cancer has remained one of the most difficult forms of cancer to treat. A new wave of research and advances in personalized treatments are bringing new hope.

Research co-authored by Providence CARDS found striking disparities in off-label prescribing of the popular GLP1-RA medications initially FDA-approved for diabetes and more recently for weight loss

Thanks in part to the work of gynecologic oncology researchers at Providence, healthcare providers and patients nationwide have a new standard of care for advanced or recurrent endometrial cancer.

A novel peptide vaccine against glioblastoma, a deadly brain tumor, is offering hope to some patients thanks to the work of an international effort including Providence's Santosh Kesari, MD, PhD.

A first-of-its-kind study on the efficacy and safety of weight loss medications in the real world is helping to provide clinicians with new is helping to provide clinicians with valuable new evidence.

The procedure using the new TriClip to repair a leaky tricuspid valve was also a first in the Pacific Northwest.

Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report

The largest study of angiosarcoma published to date, co-authored at Providence, describes the incidence and presentation patterns of angiosarcoma, a rare but potentially deadly cancer.

Two stories of how, together with our industry partners and patients, Providence is working to make the latest trials available to more people who could benefit from them.

A study led by Providence researcher Katherine Tuttle, MD, FACP, of Spokane, Washington is in the news thanks to findings around a promising new treatment for kidney disease.

A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma

The Providence Research Network 2022 Annual report highlights a year of impact and breakthroughs made possible by Providence's network of researchers, caregivers, scientists and research participants.

Clinical Trials Day is celebrated annually on May 20th. This year, to celebrate the event, we’ve released our Providence Research Network annual research report.

Providence researchers receive awards for two studies of COVID-19’s impacts on colorectal cancer screenings and outcomes

Providence researchers are studying a blood-based, multi-cancer early detection test able to detect more than 50 cancer types through a single blood draw.

Evidence outlined in a new research publication co-authored by Dr. Jason Goldman of Providence Swedish could help respond to the shortage of donated organs during COVID-19.

Providence is partnering with Stand Up To Cancer on a multi-year effort called the CHAT project focused on increasing colorectal cancer screenings in communities of color.